comparemela.com

Latest Breaking News On - Great britain summary - Page 4 : comparemela.com

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023

Investegate announcements from Galapagos NV, Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023

United kingdomRegion flamandeNorthern irelandCity ofGreat britainDaniele dambrosioAilsa hartRoberta loveikyteKristina harrisPieter jan stiersKatrien van benedenVan gijselBriang feaganTakayuki matsumotoAndreas sturmChristine rudolph

Galapagos NV: Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn s disease

The two induction cohorts missed the co-primary endpoints of clinical remission and endoscopic response at Week 10In the maintenance phase, filgotinib 200mg once daily achieved the co-primary endpoints

Region flamandeUnited kingdomNorthern irelandGreat britainDaniele dambrosioVan gijselSandra cauwenberghsMarieke vermeerschSchwierige zeitenElisa chenaillerGastroenterology department of the university hospital leuvenGroup biomedical sciencesEuropean parliamentGilead sciences incExchange commissionJapanese ministry of health

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn s disease

Investegate announcements from Galapagos NV, Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease

Region flamandeUnited kingdomNorthern irelandGreat britainDaniele dambrosioVan gijselSandra cauwenberghsMarieke vermeerschElisa chenaillerGastroenterology department of the university hospital leuvenGroup biomedical sciencesEuropean parliamentGilead sciences incExchange commissionJapanese ministry of healthEuropean union

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022

Investegate announcements from Galapagos NV, Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022

United kingdomRegion flamandeUnited statesNorthern irelandGreat britainAgustin ceraniYoshiya tanakaChristina charles schoemanKristina harrisHendrik schulze koopsPieter jan stiersJames gallowayAndreas stallmachKaren beversKatrien van benedenAnne tournadre

Galapagos NV: Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress

Five presentations demonstrate Galapagos' commitment to inflammation and the ulcerative colitis (UC) communityNew analyses will be presented from the SELECTION data set on prediction of response and remission

United kingdomRegion flamandeNorthern irelandGreat britainAgustin ceraniStefan schreiberYoshiya tanakaHaridarshan patelChristina charles schoemanHendrik schulze koopsKatrien van benedenTadakazu hisamatsuHaoyao ruanVan gijselSandra cauwenberghsEdouard louis

vimarsana © 2020. All Rights Reserved.